Abstract Number: 2238 • ACR/ARHP Annual Meeting 2014
Exploratory Six Month Phase IIa Study of a Potential Disease Modifying Drug in Patients with OA of the Knee
Background/Purpose: No disease modifying drugs exists to treat osteoarthritis. Recently, a phase II study from Tasmania showed that Zoledronic Acid, a bisphosphonate, has an effect…
ACR Meeting Abstracts